REFERENCES
- Jaffe N. Recent Advances in the Chemotherapy of Metastatic Osteogenic Sarcoma. Cancer 1972; 30: 1627–1631
- Honnegger H. P., Czerhati M. D., Exner G. U., Hochstetter A. von, Groscurt P. Z. Experience with Preoperative, High Dose Methotrexate-Containing Chemotherapy in Patients with Extremity Osteosarcoma (OSA). Ann. Oncol. 1991; 2: 498–494
- Nierenberg A., Mosende C., Mehta B. M., Gisolfi A. L., Rosen G. High-Dose Methotrexate with Citrovorum Rescue: Predictive Value of Serum Methotrexate Concentration and a Corrective Measure to Avert Toxicity. Cancer Treat. Rep. 1977; 61: 779–783
- Bleyer W. A. A Comprehensive Guide to the Therapeutic Use of Methotrexate in Bladder Cancer. Pharma. Libri., Chicago 1983; 51–69
- Umeda T., Takada N., Hodaka E., Endo F., Ishii T. Clinical Evaluation of Severe Toxicity in 54 Patients with Osteosarcoma Receiving High-Dose Methotrexate Therapy in the 365 Course. Jpn. J. Cancer Chemother. 1984; 11: 285–294
- Zimmerman H. J. Hepatotoxic Effects of Oncotherapeutic Agents. Prog. Liver Dis. 1986; 8: 621–642
- Goren M. P., Wright R. K., Horowitz M. E., Meyer W. H. Enhancement of Methotrexate Nephrotoxicity After Cisplatin Therapy. Cancer 1986; 58: 2617–2621
- Molina R., Fabian C., Cowley B. Use of Charcoal Hemoperfusion with Sequential Hemodialysis to Reduce Serum Methotrexate Level in a Patient with Acute Renal Insufficiency. Am. J. Med. 1987; 82: 350–352
- Bouffet E., Frappaz D., Laville M., Finaz J., Pinkerton C. R., Philip T., Brunat-Mentigny M. Charcoal Hemoperfusion and Methotrexate Toxicity. Lancet 1986; 1: 1497
- McIvor A. Charcoal Hemoperfusion and Methotrexate Toxicity. Nephron 1991; 58: 378
- Pond S. M. Extracorporeal Techniques in the Treatment of Poisoned Patients. Therapeutics 1991; 154: 617–622
- Montagne N., Milano G., Caldani C., Bracco J., Ayela P., Cassuto E., Thyss A., Schneider M. Removal of Methotrexate by Hemodiafiltration. Cancer Chemother. Pharmacol. 1989; 24: 400–401
- Golper T. A., Bennett W. N. Drug Removal by Continuous Arteriovenous Haemofiltration: A 341-Review of the Evidence in Poisoned Patients. Med. Toxicol. Adverse Drug Experience 1988; 3: 349